A research study co-authored by Florida Cancer Specialists & Research Institute (FCS) physicians and senior leaders will be ...

Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...

Geron Corp's Rytelo launch & robust pipeline offer a compelling investment opportunity, despite stock challenges. Click here ...

Saeed Sadeghi, MD, discusses the findings on transfusion independence achieved with treatment for patients with low-risk ...

The new findings are the first to describe distributions and perturbations of low-density granulocyte and normal-density ...

Swedish company Cantargia has enrolled the first patient in the Phase Ib/IIa trial of nadunolimab for treating individuals ...

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today an ...

Corporation announced that the European Commission has granted marketing authorization for RYTELO as a monotherapy for the ...

Forward steps are being made in HNSCC, and the first patient with MDS has been treated with iadademstat/azacitidine.

More than half of families in Delhi-NCR have been experiencing viral illness symptoms over the past month, with seasonal changes driving a surge in flu and fever cases. A LocalCircles survey found ...

A puzzling discovery has left doctors scratching their heads: The brain of an American woman with Down syndrome showed all the classic signs of Alzheimer’s disease, yet she remained symptom-free ...

Specialty chemicals company LANXESS will be presenting its innovative products and developments for a more efficient and ...